Christian Langer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christian Langer has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Bernd Hertenstein
University of Ulm
2 shared publications - Bernd Metzner
Department of Oncology and Hematology, Klinikum Oldenburg University Clinic Oldenburg Germany
2 shared publications - Christian Straka
Medizinische Klinik München Klinik Schwabing Munich Germany
2 shared publications - Georg Hess
Department of Hematology and Medical Oncology, Medical School of the Johannes Gutenberg-University, Mainz, Germany
2 shared publications - Georg Maschmeyer
German Society of Hematology and Medical Oncology (DGHO) and Charité University Medicine Berlin, Campus Benjamin Franklin; Department of Hematology, Oncology and Tumor, Charité University Medicine Berlin, Berlin, Germany
2 shared publications - Hermann Einsele
Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
2 shared publications
Latest Publications
- 4 June 2025
- Published by Taylor & Francis in Middle East Critique
- Vol. 35 (2) , 277-295
Chinese Archaeology in the Middle East: Heritage, Transnational Connectivity, and the Belt and Road Initiative
- 4 June 2025
- Published by Taylor & Francis in Middle East Critique
- Vol. 35 (2) , 277-295
Chinese Archaeology in the Middle East: Heritage, Transnational Connectivity, and the Belt and Road Initiative
- Open Access
- 21 February 2025
- Published by Cambridge University Press (CUP) in Cambridge Archaeological Journal
- Vol. 35 (2) , 305-316
The Nile and the Yellow River: Comparative Studies between Ancient Egypt and China
This paper explores the evolving landscape of comparative research between ancient Egypt and China, focusing on various aspects such as culture, writing systems, political economy, and motivations behind these comparisons done in China and international environments. Embedded with the historical context, motivations and methodologies of scholars engaged in this comparative endeavour, the authors suggest that such research is linked to modern China's intellectual history and global engagement. It discusses potential motivations, including economic factors, national agenda and interdisciplinary integration. The authors also raise the need for more deliberate theorizations of Egypt–China comparisons, emphasizing the importance of greater reflexivity and inclusivity in shaping the trajectory of comparative studies. Overall, the document sheds light on the complexities, motivations and potential impacts of Egypt–China comparative research, highlighting its relevance in understanding both historical civilizations and contemporary global dynamics.
- 21 February 2025
- Published by Cambridge University Press (CUP) in Cambridge Archaeological Journal
- Vol. 35 (2) , 305-316
Open AccessThe Nile and the Yellow River: Comparative Studies between Ancient Egypt and China
This paper explores the evolving landscape of comparative research between ancient Egypt and China, focusing on various aspects such as culture, writing systems, political economy, and motivations behind these comparisons done in China and international environments. Embedded with the historical context, motivations and methodologies of scholars engaged in this comparative endeavour, the authors suggest that such research is linked to modern China's intellectual history and global engagement. It discusses potential motivations, including economic factors, national agenda and interdisciplinary integration. The authors also raise the need for more deliberate theorizations of Egypt–China comparisons, emphasizing the importance of greater reflexivity and inclusivity in shaping the trajectory of comparative studies. Overall, the document sheds light on the complexities, motivations and potential impacts of Egypt–China comparative research, highlighting its relevance in understanding both historical civilizations and contemporary global dynamics.
- 13 March 2023
- Published by Springer Nature in Archaeologies
- Vol. 19 (1) , 39-59
Egyptology: A Decolonial Investigation
- 13 March 2023
- Published by Springer Nature in Archaeologies
- Vol. 19 (1) , 39-59
Egyptology: A Decolonial Investigation
- 9 March 2023
- Published by Springer Nature in Archaeologies
- Vol. 19 (1) , 1-27
Postcolonial Theory in Egyptology: Key Concepts and Agendas
- 9 March 2023
- Published by Springer Nature in Archaeologies
- Vol. 19 (1) , 1-27
Postcolonial Theory in Egyptology: Key Concepts and Agendas
- Open Access
- 16 August 2022
- Published by Universidade Federal da Fronteira Sul in Fronteiras: Revista Catarinense de História
- No. 40,p. 10-24
Multiculturalism and the multicultural in Ancient Egypt
This paper scrutinizes the characterization of ancient Egyptian society as multicultural and the related use of the concept and terminology of multiculturalism in research and public communications on ancient Egyptian society. An initial outline of the concept of multiculturalism sets the stage for a review of its application in specialist literature. It may seem sensible to ascribe multiculturalism or a multicultural reality to Egypt, given its history of migrations. It becomes apparent that a comprehensive theorization of multiculturalism is yet to occur with respect to ancient Egypt. This affects scholarly assessments and perceptions of historical transborder mobility and social integration.
- 16 August 2022
- Published by Universidade Federal da Fronteira Sul in Fronteiras: Revista Catarinense de História
- No. 40,p. 10-24
Open AccessMulticulturalism and the multicultural in Ancient Egypt
This paper scrutinizes the characterization of ancient Egyptian society as multicultural and the related use of the concept and terminology of multiculturalism in research and public communications on ancient Egyptian society. An initial outline of the concept of multiculturalism sets the stage for a review of its application in specialist literature. It may seem sensible to ascribe multiculturalism or a multicultural reality to Egypt, given its history of migrations. It becomes apparent that a comprehensive theorization of multiculturalism is yet to occur with respect to ancient Egypt. This affects scholarly assessments and perceptions of historical transborder mobility and social integration.
- Open Access
- 29 September 2017
- Published by Wiley in British Journal of Haematology
- Vol. 179 (4) , 586-597
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial
Summary: We assessed the safety and efficacy of bortezomib, cyclophosphamide and dexamethasone (VCD) induction therapy in previously untreated multiple myeloma patients. A total of 414 patients received three 21‐day cycles of VCD prior to autologous stem‐cell transplantation (ASCT). Most common grade ≥3 adverse events were leucopenia (31·4%) and thrombocytopenia (6·8%). The overall response rate (ORR) by investigator‐based assessment was 85·4%. Most patients (74%) underwent successful central laboratory‐based molecular cytogenetic analysis. No clinically relevant differences in ORR post‐induction were seen between patients with or without high‐risk cytogenetic abnormalities (86·2% vs. 84·3%). Further follow‐up data are available for 113 patients receiving ASCT who were included in a prospective consolidation trial (median follow‐up, 55·5 months); median progression‐free survival (PFS) was 35·3 months and median overall survival (OS) was not reached. In patients with high‐risk versus standard‐risk cytogenetics, median PFS was 19·9 vs. 43·6 months (P < 0·0001), and median OS was 54·7 months versus not reached (P = 0·0022). VCD is an effective and tolerable induction regimen; results suggest that VCD induces high response rates independently of cytogenetic risk status, but after long‐term follow‐up, cytogenetic high risk is associated with markedly reduced PFS and OS post‐ASCT.
- 29 September 2017
- Published by Wiley in British Journal of Haematology
- Vol. 179 (4) , 586-597
Open AccessPhase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial
Summary: We assessed the safety and efficacy of bortezomib, cyclophosphamide and dexamethasone (VCD) induction therapy in previously untreated multiple myeloma patients. A total of 414 patients received three 21‐day cycles of VCD prior to autologous stem‐cell transplantation (ASCT). Most common grade ≥3 adverse events were leucopenia (31·4%) and thrombocytopenia (6·8%). The overall response rate (ORR) by investigator‐based assessment was 85·4%. Most patients (74%) underwent successful central laboratory‐based molecular cytogenetic analysis. No clinically relevant differences in ORR post‐induction were seen between patients with or without high‐risk cytogenetic abnormalities (86·2% vs. 84·3%). Further follow‐up data are available for 113 patients receiving ASCT who were included in a prospective consolidation trial (median follow‐up, 55·5 months); median progression‐free survival (PFS) was 35·3 months and median overall survival (OS) was not reached. In patients with high‐risk versus standard‐risk cytogenetics, median PFS was 19·9 vs. 43·6 months (P < 0·0001), and median OS was 54·7 months versus not reached (P = 0·0022). VCD is an effective and tolerable induction regimen; results suggest that VCD induces high response rates independently of cytogenetic risk status, but after long‐term follow‐up, cytogenetic high risk is associated with markedly reduced PFS and OS post‐ASCT.
- 24 August 2015
- Published by Walter de Gruyter GmbH in Journal of Egyptian History
- Vol. 8 (1) , 49-79
The Political Realism of the Egyptian Elite: A Comparison between The Teaching For Merikare and Niccolò Machiavelli’s Il Principe
A comparison betweenThe Teaching for MerikareandNiccolò Machiavelli’sIl Principeproduces some astonishing results. WhileMachiavelli’s treatise is generally thought to be representative of the dawn of modern Western political realism, its essential properties are already present inMerikare. This includes the firm belief in strong authority, the fallibility of man, the need to appease the masses, and, if necessary, the demand to repress any developing threat to the power of the elite. In terms of the history of political thoughtMerikareis placed between the works of the moral realism of Greek philosophers like Plato and the political realism of Thucydides andMachiavelli. With the latter being heavily influenced by ancient authors, questions regarding the genesis of Greek political thought can be asked. It may well be that Greek political thought was, at least indirectly, influenced by Egyptian political thought.
- 24 August 2015
- Published by Walter de Gruyter GmbH in Journal of Egyptian History
- Vol. 8 (1) , 49-79
The Political Realism of the Egyptian Elite: A Comparison between The Teaching For Merikare and Niccolò Machiavelli’s Il Principe
A comparison betweenThe Teaching for MerikareandNiccolò Machiavelli’sIl Principeproduces some astonishing results. WhileMachiavelli’s treatise is generally thought to be representative of the dawn of modern Western political realism, its essential properties are already present inMerikare. This includes the firm belief in strong authority, the fallibility of man, the need to appease the masses, and, if necessary, the demand to repress any developing threat to the power of the elite. In terms of the history of political thoughtMerikareis placed between the works of the moral realism of Greek philosophers like Plato and the political realism of Thucydides andMachiavelli. With the latter being heavily influenced by ancient authors, questions regarding the genesis of Greek political thought can be asked. It may well be that Greek political thought was, at least indirectly, influenced by Egyptian political thought.
- Open Access
- 6 December 2014
- Published by American Society of Hematology in Blood
- Vol. 124 (21) , 43
Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma
Background In multiple myeloma (MM), the introduction of novel compounds into first-line intensive treatment pathways has clearly improved patients’ prognosis. Very recently however, specific molecular cytogenetic abnormalities, lactate dehydrogenase elevation and International Staging System 3 disease were identified to be associated with dismal prognosis despite upfront autologous (auto) stem cell transplant (SCT). Consolidative allogeneic (allo) following initial auto SCT was shown to extend progression-free survival (PFS) as well as overall survival (OS) in some prospective studies on newly diagnosed MM patients (pts). Relatively little is known on the impact of cytogenetic features other than chromosome 13q deletion (del13q) on the outcomes of pts undergoing upfront auto followed by allo (auto/allo) SCT. Patients and methods When the DSMM V treatment program was designed del13q detected by fluorescence in situ hybridisation (FISH) was accepted as one of the distinct risk factors in MM. We therefore used FISH del13q to define the study’s “high-risk” group and aimed to compare tandem high-dose melphalan 200 mg/m² (Mel) with one cycle of Mel followed by reduced-intensity conditioning (RIC) allo SCT. Allocation to either transplant regimen was by availability of an HLA-matched (at least 9/10 matches) related (MRD) or unrelated donor (MUD). Initially, all pts underwent non-novel compound cytoreduction and chemomobilization of peripheral blood stem cells (PBSC). RIC allo SCT was prepared by fludarabine and melphalan (plus ATG in MUD cases). PFS was the primary endpoint. The study was powered to detect an improvement of 2-year PFS from 20% (tandem Mel) to 40.3% (HR, 1.769). Results 199 out of 225 del13q pts with a median age of 53 (range, 30 – 60) yrs who had been enrolled between 10/2001 and 03/2007, were included in the intent-to treat population. Allo SCT was performed in 126/199 pts (63%), 74 of whom (59%) received MUD allografts. At a median follow-up of 49.2 months (mo), 2-year PFS (calculated from day 1 of second SCT) was 59% with auto/allo SCT versus 47% with tandem Mel. Median PFS with auto/allo SCT was 34.5 mo versus 21.8 mo, respectively (p=.005). Two-year non-relapse mortality (NRM) associated with auto/allo SCT was 11.9%. As of yet, there is no difference in OS between the groups, with the median not yet reached for either transplant modality. PFS/OS in auto/allo SCT were independent of donor source (MRD vs MUD). As definitions of cytogenetic risk have evolved over time, we analyzed further FISH abnormalities in pts’ baseline samples: in addition to uniform del13q, 13.6% of pts displayed del17p. Median PFS for del13q/del17p pts after HD Mel was 6 mo versus not reached with auto/allo SCT, respectively (p=.0002). Median OS in del13q/del17p after HD Mel was 23.4 mo versus not reached, respectively (p=.011). In translocation (4;14)/del13q pts (20.7%), median PFS with tandem Mel was 19.3 mo versus 19.1 with auto/allo SCT, respectively (p=.251). Conclusions This prospective trial shows auto/allo SCT to significantly extend PFS when compared to tandem HD Mel in a large cohort of del13q MM pts. It is the first study to demonstrate allo SCT in MM can be safely performed from matched unrelated donors at a reasonable rate of NRM. Utilizing a comprehensive set of FISH cytogenetics, our data for the first time demonstrate allo SCT to specifically benefit patients with high-risk features (del13q/del17p). Incremental gain of PFS when compared to tandem Mel was more than 20 months. Extended OS data on the whole study will be presented.
- 6 December 2014
- Published by American Society of Hematology in Blood
- Vol. 124 (21) , 43
Open AccessAutologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma
Background In multiple myeloma (MM), the introduction of novel compounds into first-line intensive treatment pathways has clearly improved patients’ prognosis. Very recently however, specific molecular cytogenetic abnormalities, lactate dehydrogenase elevation and International Staging System 3 disease were identified to be associated with dismal prognosis despite upfront autologous (auto) stem cell transplant (SCT). Consolidative allogeneic (allo) following initial auto SCT was shown to extend progression-free survival (PFS) as well as overall survival (OS) in some prospective studies on newly diagnosed MM patients (pts). Relatively little is known on the impact of cytogenetic features other than chromosome 13q deletion (del13q) on the outcomes of pts undergoing upfront auto followed by allo (auto/allo) SCT. Patients and methods When the DSMM V treatment program was designed del13q detected by fluorescence in situ hybridisation (FISH) was accepted as one of the distinct risk factors in MM. We therefore used FISH del13q to define the study’s “high-risk” group and aimed to compare tandem high-dose melphalan 200 mg/m² (Mel) with one cycle of Mel followed by reduced-intensity conditioning (RIC) allo SCT. Allocation to either transplant regimen was by availability of an HLA-matched (at least 9/10 matches) related (MRD) or unrelated donor (MUD). Initially, all pts underwent non-novel compound cytoreduction and chemomobilization of peripheral blood stem cells (PBSC). RIC allo SCT was prepared by fludarabine and melphalan (plus ATG in MUD cases). PFS was the primary endpoint. The study was powered to detect an improvement of 2-year PFS from 20% (tandem Mel) to 40.3% (HR, 1.769). Results 199 out of 225 del13q pts with a median age of 53 (range, 30 – 60) yrs who had been enrolled between 10/2001 and 03/2007, were included in the intent-to treat population. Allo SCT was performed in 126/199 pts (63%), 74 of whom (59%) received MUD allografts. At a median follow-up of 49.2 months (mo), 2-year PFS (calculated from day 1 of second SCT) was 59% with auto/allo SCT versus 47% with tandem Mel. Median PFS with auto/allo SCT was 34.5 mo versus 21.8 mo, respectively (p=.005). Two-year non-relapse mortality (NRM) associated with auto/allo SCT was 11.9%. As of yet, there is no difference in OS between the groups, with the median not yet reached for either transplant modality. PFS/OS in auto/allo SCT were independent of donor source (MRD vs MUD). As definitions of cytogenetic risk have evolved over time, we analyzed further FISH abnormalities in pts’ baseline samples: in addition to uniform del13q, 13.6% of pts displayed del17p. Median PFS for del13q/del17p pts after HD Mel was 6 mo versus not reached with auto/allo SCT, respectively (p=.0002). Median OS in del13q/del17p after HD Mel was 23.4 mo versus not reached, respectively (p=.011). In translocation (4;14)/del13q pts (20.7%), median PFS with tandem Mel was 19.3 mo versus 19.1 with auto/allo SCT, respectively (p=.251). Conclusions This prospective trial shows auto/allo SCT to significantly extend PFS when compared to tandem HD Mel in a large cohort of del13q MM pts. It is the first study to demonstrate allo SCT in MM can be safely performed from matched unrelated donors at a reasonable rate of NRM. Utilizing a comprehensive set of FISH cytogenetics, our data for the first time demonstrate allo SCT to specifically benefit patients with high-risk features (del13q/del17p). Incremental gain of PFS when compared to tandem Mel was more than 20 months. Extended OS data on the whole study will be presented.
- 1 January 2014
- Published by Peter Lang, International Academic Publishers
Aspekte des Imperialismus in der Außenpolitik der 18. Dynastie
- 1 January 2014
- Published by Peter Lang, International Academic Publishers
Aspekte des Imperialismus in der Außenpolitik der 18. Dynastie
- 1 January 2002
- Published by Springer Nature
- p. 273-278
Schlußbetrachtung